ORIC
Oric Pharmaceuticals Inc
13.20$
-1.1%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
Oric Pharmaceuticals Inc (ORIC) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -32 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -5.5 | -5.5 | -5.4 | -7.1 | -8.3 | -9.6 | -9.6 | -18 | -15 | -17 | -12 | -16 | -23 | -18 | -19 | -15 | -21 | -21 | -20 | -24 | -30 | -26 | -29 | -28 | -33 | -31 | -25 | -22 | -32 | -32 | -112 | |
| 0.2 | 0.2 | 0.3 | 0.3 | 0.3 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.3 | 0.2 | 0.2 | 0.2 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 1.1 | |
| 0.2 | 0.2 | 0.3 | 0.4 | 0.5 | 1.4 | 1.7 | 1.7 | 2.7 | 3.2 | 3.4 | 3.5 | 3.9 | 4.1 | 3.3 | 3.1 | 3.6 | 3.8 | 3.9 | 3.9 | 5.0 | 5.0 | 5.1 | 5.2 | 6.6 | 6.6 | 5.6 | 6.3 | 6.9 | 7.1 | 26 | |
| 0.2 | 0.2 | 0.3 | – | 0.5 | 1.4 | 15 | 8.8 | 2.7 | 3.6 | 3.4 | 3.5 | 3.9 | 4.1 | 3.3 | 3.2 | 3.6 | 3.8 | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 0.1 | 0.0 | 0.6 | 0.5 | -0.2 | -0.2 | 1.0 | 1.4 | -1.8 | 0.9 | 2.3 | 2.6 | -3.8 | -1.7 | 2.4 | 2.7 | 0.3 | -1.0 | 3.6 | 2.0 | -8.2 | 3.4 | 2.4 | 4.4 | -8.5 | -0.8 | 2.1 | 1.7 | -4.0 | 2.2 | 2.0 | |
| 0.1 | 0.4 | 0.2 | 0.1 | 0.0 | 0.2 | 0.1 | 0.4 | 0.2 | 0.1 | 0.2 | 0.4 | 0.7 | 0.7 | 0.4 | 0.3 | 0.3 | 0.4 | 0.1 | 0.1 | 0.2 | 0.3 | 0.4 | 0.2 | 0.4 | 0.1 | 0.0 | 0.4 | 0.0 | 0.4 | 0.8 | |
| -0.1 | -0.4 | -0.2 | -0.1 | 0.2 | -0.2 | -125 | -91 | 41 | 82 | 35 | 0.4 | -91 | -46 | -0.7 | 28 | 13 | -19 | -58 | 21 | -62 | 18 | 23 | 43 | 22 | -77 | -111 | 17 | -18 | 12 | -100 | |
| 15 | – | – | – | 0.0 | – | – | – | 0.0 | 0.1 | 50 | 0.8 | 0.0 | 0.4 | 0.0 | 0.5 | – | 8,601 | 8,620 | -17,220 | – | 10,951 | -10,951 | – | – | – | – | – | – | -1.3 | – | |
| 15 | 50 | 5.7 | -0.1 | -1.6 | 127 | -0.3 | 125 | 0.0 | 0.1 | 49 | 0.8 | 0.0 | 0.4 | 0.0 | 25 | 85 | 85 | 0.0 | 0.5 | 125 | 0.8 | 0.1 | 0.6 | 0.3 | 134 | 109 | 1.5 | 61 | 0.8 | 173 | |
| 9.6 | 44 | 0.1 | -7.3 | 79 | 117 | -135 | 16 | 26 | 66 | 72 | -15 | -113 | -64 | -20 | 38 | -7.9 | 45 | -77 | -2.9 | 33 | -6.5 | -5.6 | 15 | -10 | 27 | -26 | -4.0 | 11 | -19 | -38 | |
| -5.6 | -5.9 | -5.6 | -7.2 | -8.3 | -9.8 | -9.6 | -18 | -15 | -17 | -12 | -17 | -23 | -18 | -20 | -16 | -21 | -22 | -20 | -24 | -31 | -26 | -29 | -28 | -33 | -31 | -25 | -23 | -32 | -32 | -112 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.